Yes, Women Need Testosterone
Women produce testosterone in their ovaries and adrenal glands — at roughly 1/10th to 1/20th the amount men produce, but it's biologically essential. Testosterone in women supports energy, libido, mood, cognitive function, bone density, and muscle maintenance. When levels decline — particularly during perimenopause and menopause — the symptoms can be profound and are frequently misattributed to "just aging" or confused with estrogen-only deficiency. Testosterone therapy for women is an underutilized but evidence-supported intervention.
The women's health conversation around menopause has historically focused on estrogen and progesterone, with testosterone treated as an afterthought. This is changing. Research increasingly demonstrates that testosterone plays a vital role in female physiology, and that addressing testosterone deficiency alongside estrogen and progesterone produces better outcomes than estrogen replacement alone.
Symptoms of Low T in Women
- Persistent fatigue that doesn't improve with adequate sleep
- Loss of libido — the most commonly reported and well-studied symptom
- Decreased sexual satisfaction and reduced arousal response
- Brain fog and difficulty concentrating
- Mood changes — increased anxiety, irritability, or flat affect
- Muscle weakness and reduced exercise tolerance
- Bone density loss beyond what's expected from estrogen decline alone
- Thinning hair (different mechanism than male pattern baldness)
These symptoms overlap heavily with estrogen deficiency and thyroid dysfunction, which is why comprehensive testing — not guesswork — is essential for accurate diagnosis.
When It Happens
Testosterone declines gradually in women starting in the late 20s to early 30s. By the time a woman reaches menopause, testosterone levels may be roughly half of what they were at peak production. Specific triggers for more acute decline include:
- Surgical menopause (oophorectomy) — removes the primary testosterone-producing organs, causing an immediate and dramatic decline
- Natural menopause — gradual decline accelerated by ovarian function cessation
- Oral contraceptives — can significantly increase SHBG, reducing bioavailable testosterone
- Adrenal insufficiency — reduces the secondary source of female testosterone production
Testing for Women
Women's testosterone testing requires different reference ranges than men's. A standard male hormone panel won't be appropriately calibrated. Key markers:
| Marker | Purpose | Typical Female Range |
|---|---|---|
| Total testosterone | Overall T status | 15–70 ng/dL (premenopausal) |
| Free testosterone | Bioavailable fraction | 0.3–1.9 ng/dL |
| SHBG | Binding capacity | 18–144 nmol/L |
| Estradiol | Concurrent evaluation | Varies by cycle/menopause |
| DHEA-S | Adrenal androgen status | Age-dependent |
Many at-home test kits now offer women's hormone panels that include these markers with appropriate female reference ranges.
Treatment Options
Testosterone therapy for women typically uses much lower doses than male protocols:
- Compounded testosterone cream: The most common delivery method for women. Applied to the inner thigh, upper arm, or vulvar area. Doses typically range from 0.5–5mg/day — roughly 1/20th to 1/40th of male TRT doses.
- Testosterone pellets: Subcutaneous pellets that release testosterone steadily over 3–4 months. Some clinics specialize in this approach for women.
- DHEA supplementation: DHEA is a precursor hormone that converts to both testosterone and estrogen. Oral or vaginal DHEA (Intrarosa/prasterone) is FDA-approved for vulvovaginal atrophy and can modestly increase testosterone.
Dosing Differences
The most critical difference between male and female testosterone therapy is the dose. Women's bodies are exquisitely sensitive to testosterone, and the therapeutic window is narrow:
| Parameter | Male TRT | Female Testosterone Therapy |
|---|---|---|
| Typical dose | 80–200mg/week | 0.5–5mg/day (3.5–35mg/week) |
| Target total T | 500–1,000 ng/dL | 30–70 ng/dL |
| Delivery method | Injections (primary) | Compounded cream (primary) |
| Monitoring frequency | Every 6–12 weeks initially | Every 4–8 weeks initially |
Finding the Right Provider
Not all TRT clinics serve women. Many are exclusively focused on male hormone therapy. Clinics that specifically offer women's testosterone therapy include:
- Fountain TRT — expanded into women's HRT in 2025, offering concierge-style hormone management for both men and women
- Integrative medicine and longevity clinics — practices focused on comprehensive hormone optimization often serve both genders
- Menopause specialists — OB/GYNs and endocrinologists with menopause certification often prescribe testosterone as part of comprehensive HRT
When evaluating a provider for women's testosterone therapy, key questions include: Do they have experience specifically with female patients? Do they use appropriate female reference ranges? Do they monitor for virilization side effects? Do they coordinate testosterone with estrogen and progesterone management?